Also trades as: IN.TO (TSX) · $vol 0M
INM NASDAQ
InMed Pharmaceuticals Inc.
1W: -3.6%
1M: -1.5%
3M: -17.4%
YTD: +18.8%
1Y: -40.1%
3Y: -90.6%
5Y: -99.8%
$1.33
-0.02 (-1.48%)
Weekly Expected Move ±5.8%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$3M
-85.7% ▼
5Y CAGR: -20.9%
Total Liabilities
$2M
-33.1% ▼
5Y CAGR: -4.1%
Shareholders Equity
$1M
-94.1% ▼
5Y CAGR: -32.0%
Cash & Investments
$2M
-85.2% ▼
5Y CAGR: -21.4%
Total Debt
$0
-100.0% ▼
Net Debt
-$2M
+84.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8M | $9M | $7M | $15M | $2M |
| Short-Term Investments | $58K | $0 | $0 | $0 | $40K |
| Cash & ST Investments | $8M | $9M | $7M | $15M | $2M |
| Net Receivables | $113K | $260K | $353K | $634K | $0 |
| Inventory | $3M | $2M | $1M | $1M | $0 |
| Other Current Assets | $2 | $542K | $521K | $497K | $447K |
| Total Current Assets | $12M | $11M | $9M | $18M | $3M |
| Property, Plant & Equip. | $1M | $723K | $1M | $1M | $221M |
| Goodwill & Intangibles | $3M | $2M | $2M | $2M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $227K | $105K | $100K | $136K | -$221M |
| Total Non-Current Assets | $4M | $3M | $3M | $4M | $353K |
| Total Assets | $16M | $14M | $12M | $21M | $3M |
| — Liabilities — | |||||
| Accounts Payable | $2M | $544K | $626K | $504K | $927K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $644K | $558K | $488K | $668K | $1M |
| Total Current Liabilities | $4M | $2M | $2M | $3M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $1 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $501K | $16K | $645K | $417K | $0 |
| Total Liabilities | $5M | $2M | $3M | $3M | $2M |
| — Equity — | |||||
| Common Stock | $91M | $78M | $83M | $124M | $94M |
| Retained Earnings | -$120M | -$101M | -$109M | -$160M | -$130M |
| Accumulated OCI | $166K | $129K | $129K | $175K | $129K |
| Total Stockholders Equity | $12M | $12M | $9M | $18M | $1M |
| Total Liabilities & Equity | $16M | $14M | $12M | $21M | $3M |
| — Key Metrics — | |||||
| Total Debt | $1M | $392K | $963K | $1M | $0 |
| Net Debt | -$7M | -$9M | -$6M | -$14M | -$2M |
| Total Investments | $58K | $0 | $0 | $0 | $40K |